EUVIMEDEUVIMED entdecken
Crossref

Proteome Aggregation in Cells Derived from Amyotrophic Lateral Sclerosis Patients for Personalized Drug Evaluation

Carmen Pérez de la Lastra Aranda, Carlota Tosat-Bitrián, Gracia Porras, Ruxandra Dafinca, Diego Muñoz-Torrero iD, Kevin Talbot, Ángeles Martín-Requero, Ana Martínez iD, Valle Palomo iD

ACS Chemical Neuroscience · 2024

DOI: 10.1021/acschemneuro.4c00328 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2024. Verfasst von Carmen Pérez de la Lastra Aranda und 8 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Madrileño de Estudios Avanzados en Nanociencia (IMDEA Nanociencia), C/Faraday 9, 28049 Madrid, Spain. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Proteome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: European Commission, Ministerio de Ciencia e Innovaci?n, 'la Caixa' Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisProteomeHumansPrecision MedicineMotor NeuronsLymphocytesProtein AggregatesInduced Pluripotent Stem CellsProtein Aggregation, PathologicalDNA-Binding ProteinsDrug Evaluation, PreclinicalMutation

Stichwörter der Autor:innen

amyotrophic lateral sclerosispatient samplespersonalized drug evaluationprotein aggregationturbidity

Substanzen

ProteomeProtein AggregatesDNA-Binding ProteinsTARDBP protein, human

Autor:innen und Institutionen

  • Instituto Madrileño de Estudios Avanzados en Nanociencia (IMDEA Nanociencia), C/Faraday 9, 28049 Madrid, Spain.
  • Centro de Investigaciones Biológicas "Margarita Salas"-CSIC, Ramiro de Maeztu 9, 28040 Madrid, Spain.
  • Oxford Motor Neuron Disease Centre, Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, U.K.
  • Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford OX1 3QU, U.K.
  • Laboratory of Medicinal Chemistry (CSIC Associated Unit), Faculty of Pharmacy and Food Sciences, and Institute of Biomedicine (IBUB), University of Barcelona (UB), Av. Joan XXIII 27-31, E-08028 Barcelona, Spain.
  • Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas, (CIBERNED), Instituto de Salud Carlos III, Av. Monforte de Lemos, 3-5, 28029 Madrid, Spain.

ORCID-Profile: Diego Muñoz-Torrero, Ana Martínez, Valle Palomo

Förderung

  • European Commission
  • Ministerio de Ciencia e Innovaci?n
  • 'la Caixa' Foundation
  • Ministerio de Educaci?n, Cultura y Deporte
  • European Social Fund Plus
  • European Molecular Biology Organization
  • Fundaci?n HNA

Zitieren

APA

Pérez de la Lastra Aranda, C., Tosat-Bitrián, C., Porras, G., Dafinca, R., Muñoz-Torrero, D., Talbot, K., Martín-Requero, Á., Martínez, A., & Palomo, V. (2024). Proteome Aggregation in Cells Derived from Amyotrophic Lateral Sclerosis Patients for Personalized Drug Evaluation. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.4c00328

Vancouver

Pérez de la Lastra Aranda C, Tosat-Bitrián C, Porras G, Dafinca R, Muñoz-Torrero D, Talbot K, et al. Proteome Aggregation in Cells Derived from Amyotrophic Lateral Sclerosis Patients for Personalized Drug Evaluation. ACS Chemical Neuroscience. 2024. doi:10.1021/acschemneuro.4c00328

BibTeX
@article{PrezdelaLastraAranda2024,
  author = {Pérez de la Lastra Aranda, Carmen and Tosat-Bitrián, Carlota and Porras, Gracia and Dafinca, Ruxandra and Muñoz-Torrero, Diego and Talbot, Kevin and Martín-Requero, Ángeles and Martínez, Ana and Palomo, Valle},
  title = {Proteome Aggregation in Cells Derived from Amyotrophic Lateral Sclerosis Patients for Personalized Drug Evaluation},
  journal = {ACS Chemical Neuroscience},
  year = {2024},
  doi = {10.1021/acschemneuro.4c00328}
}
Kostenlos starten →